<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Our Mission</title>
    <link rel="stylesheet" href="style.css">

</head>
<body>

<div style="text-align:center">
    <div class="navbar">
        <a href="index.html">Home</a>
	<a href="mission.html" class = "active">Our Mission</a>
        <a href="biomimetics.html">Biomimetics</a>
        <a href="micromist.html">µMist</a>
        <a href="microlot.html">µLot</a>
	<a href="team.html">About Us</a>
	<a href="news.html">News</a>
    </div>
</div>




<!-- Left column -->
<div class="container">
    <div class="row">
        <div class="column-66">
            <h1 class="xlarge-font"><b>What is our mission?</b></h1>
            <h1 class="medium-font" style="color:MediumSeaGreen;"><b>The vision of Swedish Biomimetics 3000® AB is to find, develop and launch technologies inspired by nature, a scientific approach referred to as biomimetics</b></h1>
            
        </div>
        <div class="column-33">

        </div>
    </div>
</div>

<!-- Right Column -->
<div class="container" style="background-color:#f1f1f1">
    <div class="row">
        <div class="column-33" style="padding-left: 150px">
            <img src="assets\contents.png" width="294" height="441">
        </div>
        <div class="column-66">
	 <h4 class="large-font" style="text-align: right"><b>We aim to use what nature has refined over millions of years and apply that to today’s technological challenges</b></h4>
       <h4 class="medium-font" style="text-align: justify"> SB3000® AB provide a platform for developing biomimetic technologies, which we believe is the solution to a sustainable eco-friendly future; where health, environmental consciousness and sound economic benefits converge </h4>
             <h4 class="medium-font" style="text-align: justify"> We are a key player in a fast growing global biomimetics market, launching technologies aimed at three big industrial sectors; pharmaceuticals, automotive and consumer care </h4>
           
		<h4 class="medium-font"><b>The Commerical Strategy </b></h4>
            

            <li>Our mission is to form, finance and support technology specific Special Purpose Entities (SPEs) engaged in the development of Intellectual Property derived from biomimetic concepts. </li> <br>

            <li>The working model is to enter into joint development and funding agreements with global, area specific, industrial partners.</li> <br> 
            <li> The SPEs operate as biotech start-ups where the upcoming revenues are coming from product sales, product/process licenses and royalties. They are run in such a way that they have highly valuable M&A targets or IPO candidates in their own right. </li> <br> 
                
            <li> Today, the SB3000® AB Holding portfolio includes two, majority owned, Special Purpose Entities: </li>
 
<br>
           


        </div>
    </div>




</div>








</div>




</div>





</body>
</html>
